Zobrazeno 1 - 10
of 56
pro vyhledávání: '"E B, Keeffe"'
Autor:
S. A. Gonzalez, E. B. Keeffe
Publikováno v:
International Journal of Clinical Practice. 66:7-10
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death (1). Chronic infection with hepatitis B virus (HBV) is a major risk factor for HCC, accounting for more than one half of cases worldwide (2). Early detection of HCC in populati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3036cca10d004a6f6e9c807c9001bfe6
https://doi.org/10.1111/j.1742-1241.2011.02808.x
https://doi.org/10.1111/j.1742-1241.2011.02808.x
Autor:
E. B. Keeffe, W. S. Ayoub
Publikováno v:
Alimentary Pharmacology & Therapeutics. 34:1145-1158
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4b43a5739096f110cdb2c3e25862c0a
https://doi.org/10.1111/j.1365-2036.2011.04869.x
https://doi.org/10.1111/j.1365-2036.2011.04869.x
Autor:
B, Degertekin, Steven-Huy B, Han, E B, Keeffe, E R, Schiff, V A, Luketic, R S, Brown, S, Emre, C, Soldevila-Pico, K R, Reddy, M B, Ishitani, T T, Tran, T L, Pruett, A S F, Lok, Morton, Brown
Publikováno v:
American Journal of Transplantation. 10:1823-1833
The availability of hepatitis B immune globulin (HBIG) and several oral antiviral therapies has reduced but not eliminated hepatitis B virus (HBV) recurrence. We aimed to determine the rate of HBV recurrence after orthotopic liver transplantation (OL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cb5827d65954c77087c96eee72a23f0
https://doi.org/10.1111/j.1600-6143.2010.03046.x
https://doi.org/10.1111/j.1600-6143.2010.03046.x
Autor:
I M, Gralnek, R D, Hays, A, Kilbourne, H R, Rosen, E B, Keeffe, L, Artinian, S, Kim, D, Lazarovici, D M, Jensen, R W, Busuttil, P, Martin
Publikováno v:
American Journal of Gastroenterology. 95:3552-3565
Assessment of health-related quality of life (HRQOL) outcomes in studies of liver disease and liver transplantation is necessary. Reliable and valid disease-targeted HRQOL measures are thus needed. The objective of this study was to develop a reliabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b94d6cf2af0c485c00789f276984c9f
https://doi.org/10.1111/j.1572-0241.2000.03375.x
https://doi.org/10.1111/j.1572-0241.2000.03375.x
Autor:
P. J. Pockros, M. Tong, W. M. Lee, D. J. Van Leeuwen, E. B. Keeffe, K. Bala, P. G. Killenberg, R. T. Foust, H. J. Rosenblate, K. M. Payne, H. Fromm, H. R. Lesesne, M. Black, The Consensus Interferon Study Group
Publikováno v:
Journal of Viral Hepatitis. 5:271-276
We have investigated the relationship between serum alanine aminotransferase (ALT) and hepatitis C virus (HCV) RNA in the assessment of responses to interferon (IFN) therapy in chronic HCV infection. Data from 704 patients with HCV infection who were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::786dd8a76391a4517b7a9ae7b3895b8a
https://doi.org/10.1046/j.1365-2893.1998.00114.x
https://doi.org/10.1046/j.1365-2893.1998.00114.x
Autor:
L M Blatt, M Klein, Myron J. Tong, F B Hollinger, M Black, H White, R T Foust, J Lubina, D M Jensen, William M. Lee, H Fromm, E J Hathcote, E B Keeffe, E L Krawitt, K R Reddy, P J Pockros, J C Hoefs
Publikováno v:
Hepatology. 26:747-754
This multicenter, randomized, controlled, double-blind, phase III study in 704 patients with chronic hepatitis C infection compared treatment with consensus interferon (CIFN), a non-natural recombinant type-1 interferon, with a standard regimen of re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fda4821f7197ae02fb5ee1e58c6aea71
https://doi.org/10.1002/hep.510260330
https://doi.org/10.1002/hep.510260330
Autor:
S A, Gonzalez, E B, Keeffe
Publikováno v:
International journal of clinical practice. 66(1)
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death (1). Chronic infection with hepatitis B virus (HBV) is a major risk factor for HCC, accounting for more than one half of cases worldwide (2). Early detection of HCC in populati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::63a34aad3f2a92bbc96410d5464f2db6
https://pubmed.ncbi.nlm.nih.gov/22171899
https://pubmed.ncbi.nlm.nih.gov/22171899
Autor:
M, Morgan, E B, Keeffe
Publikováno v:
Minerva gastroenterologica e dietologica. 55(1)
The diagnosis of chronic hepatitis B (CHB) is made using a combination of serological, virologic, biochemical, and histologic markers. The natural history of hepatitis B virus (HBV) infection can be divided into four phases: immune tolerance, immune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bc03c8173601813ac5d2f51d4d38d4bf
https://pubmed.ncbi.nlm.nih.gov/19212304
https://pubmed.ncbi.nlm.nih.gov/19212304
Publikováno v:
Alimentary pharmacologytherapeutics. 26(6)
Transcatheter arterial chemoembolization (TACE) has become one of the most common treatments for unresectable hepatocellular carcinoma. Published studies of TACE report a 5-16% risk of serious complications. Compared with TACE, transcatheter arterial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f2a2fb68a4809ac5fba9e722ffe4a004
https://pubmed.ncbi.nlm.nih.gov/17767468
https://pubmed.ncbi.nlm.nih.gov/17767468
Publikováno v:
Minerva gastroenterologica e dietologica. 53(1)
The diagnosis of chronic hepatitis B virus (HBV) infection is made using a combination of serological, virologic, biochemical, and histologic markers. The natural history of HBV infection can be divided into four phases: immune tolerance, immune clea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a8bf2f7185bce2c415f612d6f216a6d1
https://pubmed.ncbi.nlm.nih.gov/17415343
https://pubmed.ncbi.nlm.nih.gov/17415343